Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of the Phase I Safety and Immunogenicity Trial of Recombinant HIV-1 Tat in Hiv-1 Infected Adult Volunteers

NCT01024595 is registered in ClinicalTrials.gov with Istituto Superiore di Sanità as lead sponsor.

NCT NCT01024595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01024595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of the Phase I Safety and Immunogenicity Trial of Recombinant HIV-1 Tat in Hiv-1 Infected Adult Volunteers
Lead sponsor
Istituto Superiore di Sanità
Phase
Observational
Overall status
Completed
Start date
September 30, 2007
Completion date
December 31, 2010
Enrollment
24 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection